DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
TAK-228 is an investigational drug.
There have been 322 clinical trials for TAK-228. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2007.
The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).
Recent Clinical Trials for TAK-228
|A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia||Millennium Pharmaceuticals, Inc.||Phase 1|
|A Study of TAK-994 in Participants With Narcolepsy Type 1||Takeda||Phase 1|
|A Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics Study||Millennium Pharmaceuticals, Inc.||Phase 1|